title: A critical assessment of the potential of short interfering RNA therapeutics.
abstract: siRNA technology is now being extensively investigated both academically and commercially as a therapeutic modality because of its ability, at low concentration, to effectively downregulate the expression of target genes in tissue culture. However, the road to therapeutic siRNAs, similar to antisense oligodeoxyribonucleotides, an older technology that is also based on Watson-Crick base-pair complementation and which have not performed well in the clinic, will undoubtedly be long and challenging despite the initial enthusiasm.:
authors: Department of Oncology, Albert Einstein-Montefiore Cancer Center, 111 E. 210 St. Bronx, NY 10461, USA. Electronic address:cstein@montefiore.org.
authors: C A
authors: CA
authors: Stein
authors: Beckman Research Institute, City of Hope National Medical Center, 1450 E. Duarte Road, Duarte, CA 91010, USA.
authors: J J
authors: JJ
authors: Rossi